In short
Paraffin White Soft, a common ingredient in moisturizers, is being studied in clinical trials for its potential benefits in treating and preventing atopic dermatitis, especially in children. These trials aim to evaluate the effectiveness of moisturizers containing Paraffin White Soft in managing eczema symptoms, preventing relapses, and potentially preventing the onset of atopic dermatitis in high-risk infants. The studies focus on the drug's ability to improve skin hydration, reduce inflammation, and maintain skin barrier function in patients with this chronic skin condition.
At a glance
- Study Drug
- Paraffin White Soft (in combination with other ingredients)
- Target Condition
- Atopic Dermatitis (Eczema)
- Study Populations
- Children 2-12 years old with mild to moderate AD; Newborns <3 weeks with high familial AD risk
- Primary Objectives
- Prevent eczema relapse; Prevent AD onset in high-risk infants
- Key Measurements
- SCORAD, Quality of Life, Time to relapse, Cumulative AD incidence
- Study Duration
- 6-12 months
- Application Method
- Topical (applied to skin)
- Additional Assessments
- Skin microbiome, Genetic factors (FLG mutations), Allergen sensitization
What is Paraffin White Soft?
Paraffin White Soft, also known as soft white paraffin or white petrolatum, is a common ingredient in moisturizing creams and ointments. It is often combined with liquid paraffin to create emollient products. These substances are used in skincare products to help moisturize and protect the skin.
Medical Uses
Paraffin White Soft is primarily used in the treatment and management of dry skin conditions, particularly atopic dermatitis (also known as eczema). Atopic dermatitis is a chronic, itchy skin condition that often affects children but can persist into adulthood.
Effectiveness in Treating Atopic Dermatitis
Clinical trials are being conducted to evaluate the effectiveness of moisturizers containing Paraffin White Soft in treating and preventing atopic dermatitis. One study aims to demonstrate the superiority of a newly developed moisturizer in preventing eczema relapse in children with atopic dermatitis compared to a reference cream.
Another study is investigating the potential of a moisturizing barrier-stabilizing skin cream containing Paraffin White Soft in preventing the development of atopic dermatitis symptoms in high-risk children. This research focuses on the cream's ability to reduce the cumulative incidence of atopic dermatitis in infants with a high familial risk of the condition.
Application and Dosage
The application of Paraffin White Soft-containing products varies depending on the specific formulation and the patient's needs. In clinical trials, the maximum daily dose ranged from 12 to 18 ml or grams, with treatment periods lasting up to 6-13 months. However, it's important to note that these dosages are specific to the studies and may not reflect general usage recommendations.
Potential Benefits
The use of moisturizers containing Paraffin White Soft may offer several potential benefits for individuals with atopic dermatitis: Prevention of eczema relapse Reduction in disease severity Improvement in quality of life Possible delay or prevention of atopic dermatitis onset in high-risk infants
Safety and Side Effects
Paraffin White Soft is generally considered safe for topical use. However, as with any medical treatment, there may be potential side effects or adverse reactions. Clinical trials are assessing the tolerability and safety of products containing this ingredient. It's important to consult with a healthcare provider before starting any new treatment regimen, especially for children or individuals with sensitive skin.
Ongoing Research
Current clinical trials are investigating various aspects of Paraffin White Soft-containing moisturizers, including: Their effect on preventing eczema relapse in children The potential to prevent atopic dermatitis symptoms in high-risk infants Impact on disease severity and quality of life Effects on skin microbiome Relationship between treatment effects and genetic factors (such as filaggrin gene mutations)
These studies aim to provide more comprehensive data on the efficacy and safety of Paraffin White Soft in managing and preventing atopic dermatitis.